Add like
Add dislike
Add to saved papers

Colloidal Precursor-Induced Growth of Ultra-Even CH 3 NH 3 PbI 3 for High-Performance Paintable Carbon-Based Perovskite Solar Cells.

Carbon-based hole transport material (HTM)-free perovskite solar cells (PSCs) have attracted intense attention due to their relatively high stability. However, their power conversion efficiency (PCE) is still low, especially for the simplest paintable carbon-based PSCs (C-PSCs), whose performance is greatly limited by poor contact at the perovskite/carbon interface. To enhance interface contact, it is important to fabricate an even-surface perovskite layer in a porous scaffold, which is not usually feasible due to roughness of the crystal precursor. Herein, colloidal engineering is applied to replace the traditional crystal precursor with a colloidal precursor, in which a small amount of dimethyl sulfoxide (DMSO) is added into the conventional PbI2 dimethylformamide (DMF) solution. After deposition, PbI2 (DMSO) adduct colloids (which are approximately tens of nanometers in size) are stabilized and dispersed in DMF to form a colloidal film. Compared with PbI2 and PbI2 (DMSO) adduct crystal precursors deposited from pure DMF and DMSO solvents, respectively, the PbI2 (DMSO) adduct colloidal precursor is highly mobile and flexible, allowing an ultra-even surface to be obtained in a TiO2 porous scaffold. Furthermore, this ultra-even surface is well-maintained after chemical conversion to CH3 NH3 PbI3 in a CH3 NH3 I solution. As a result, the contact at the CH3 NH3 PbI3 /carbon interface is significantly enhanced, which largely boosts the fill factor and PCE of C-PSCs. Impressively, the achieved champion PCE of 14.58% is among the highest reported for C-PSCs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app